FELICIA HOERNER: Open Payments
NPI 1477112688 · NEWTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,145 in 68 payments from 14 companies in 2025. Trend: 2023 $1,296 · 2024 $1,649 · 2025 $1,145
Food & beverage: $1,145
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 13 | $208 |
| Otsuka America Pharmaceutical, Inc. | 11 | $204 |
| ABBVIE INC. | 9 | $143 |
| Alkermes, Inc. | 9 | $140 |
| Vanda Pharmaceuticals Inc. | 4 | $88 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $81 |
| MDD US Operations, LLC | 4 | $65 |
| Lundbeck LLC | 4 | $62 |
| Neurocrine BioSciences, Inc. | 4 | $60 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
Products named: AUSTEDO XR, VRAYLAR, ARISTADA, REXULTI, ABILIFY MAINTENA, FANAPT, CAPLYTA, Qelbree.
Industry payments across IA — which companies pay providers there.
